PART I . Overview Trulieve Cannabis Corp. is a reporting issuer in the United States and Canada. The Companys Subordinate Voting Shares (as hereinafter defined) are listed for trading on the Canadian Securities Exchange (CSE) under the symbol TRUL and are also traded in the United States on the OTCQX Best Market (OTCQX) under the symbol TCNNF. The Company qualifies as a wellknown seasoned issuer ("WKSI") under National Instrument 44102 ("NI 44-102") and is eligible to file a WKSI base shelf pros...
Q2 FY2026 — expected 2026-08-12
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | TCNNF | discussed_in_filing Cybersecurity | |
| topic_mention | TCNNF | discussed_in_filing Trusted Computing | |
| topic_mention | TCNNF | discussed_in_filing Blockchain & Crypto | |
| topic_mention | TCNNF | discussed_in_filing Capital Expenditure | |
| topic_mention | TCNNF | discussed_in_filing Supply Chain | |
| topic_mention | TCNNF | discussed_in_filing Regulation | |
| topic_mention | TCNNF | discussed_in_filing Enterprise | |
| topic_mention | TCNNF | discussed_in_filing Automotive | |
| topic_mention | TCNNF | discussed_in_filing Healthcare & Bio | |
| topic_mention | TCNNF | discussed_in_filing AI Compute | |
| topic_mention | TCNNF | discussed_in_filing Platform & Ecosystem | |
| topic_mention | TCNNF | discussed_in_filing Sovereign & Government | |
| topic_mention | TCNNF | discussed_in_filing Cybersecurity | |
| topic_mention | TCNNF | discussed_in_filing Trusted Computing | |
| topic_mention | TCNNF | discussed_in_filing Blockchain & Crypto | |
| topic_mention | TCNNF | discussed_in_filing Capital Expenditure | |
| topic_mention | TCNNF | discussed_in_filing Supply Chain | |
| topic_mention | TCNNF | discussed_in_filing Regulation | |
| topic_mention | TCNNF | discussed_in_filing Enterprise | |
| topic_mention | TCNNF | discussed_in_filing Automotive |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001754195-26-000019 | EDGAR | 54K words |
| 2025-02-27 | 2024-12-31 | 0001628280-25-008421 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001628280-24-007779 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0000950170-23-006575 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0000950170-22-004989 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001564590-21-014684 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001754195-25-000067 | EDGAR | 18K words |
| 2025-08-06 | 2025-06-30 | 0001754195-25-000053 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001754195-25-000037 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001628280-24-045099 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001628280-24-034971 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001628280-24-021919 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001628280-23-038010 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040145 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020030 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023916 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016239 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009453 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-05 | 0001754195-26-000021 | EDGAR | 11K words |
| 2026-02-26 | 0001754195-26-000017 | EDGAR | — |
| 2026-02-18 | 0001754195-26-000014 | EDGAR | — |
| 2026-01-29 | 0001754195-26-000005 | EDGAR | — |
| 2025-12-17 | 0001754195-25-000074 | EDGAR | — |
| 2025-12-09 | 0001754195-25-000071 | EDGAR | — |
| 2025-11-05 | 0001754195-25-000064 | EDGAR | — |
| 2025-11-04 | 0001754195-25-000062 | EDGAR | — |
| 2025-08-27 | 0001754195-25-000057 | EDGAR | — |
| 2025-08-06 | 0001754195-25-000051 | EDGAR | — |
95 total filings indexed. 67 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001754195 |
| Ticker | TCNNF |
| Exchange | OTC |
| SIC | 2833: Medicinal Chemicals & Botanical Products |
| Incorporated | A1 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report